Alps Advisors Inc. Boosts Holdings in Exponent, Inc. $EXPO

Alps Advisors Inc. grew its position in Exponent, Inc. (NASDAQ:EXPOFree Report) by 65.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 120,306 shares of the business services provider’s stock after purchasing an additional 47,640 shares during the quarter. Alps Advisors Inc. owned about 0.24% of Exponent worth $8,359,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Bessemer Group Inc. increased its position in Exponent by 21.7% during the 2nd quarter. Bessemer Group Inc. now owns 829 shares of the business services provider’s stock valued at $62,000 after buying an additional 148 shares in the last quarter. HM Payson & Co. increased its holdings in shares of Exponent by 33.9% during the third quarter. HM Payson & Co. now owns 589 shares of the business services provider’s stock valued at $41,000 after acquiring an additional 149 shares in the last quarter. Heritage Family Offices LLP raised its position in shares of Exponent by 4.5% in the 3rd quarter. Heritage Family Offices LLP now owns 3,627 shares of the business services provider’s stock valued at $252,000 after purchasing an additional 155 shares during the last quarter. Arizona State Retirement System boosted its stake in Exponent by 1.1% in the 3rd quarter. Arizona State Retirement System now owns 14,984 shares of the business services provider’s stock worth $1,041,000 after purchasing an additional 162 shares in the last quarter. Finally, Franklin Resources Inc. grew its position in Exponent by 4.4% during the 2nd quarter. Franklin Resources Inc. now owns 4,070 shares of the business services provider’s stock worth $304,000 after purchasing an additional 173 shares during the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Insider Buying and Selling at Exponent

In other news, CEO Catherine Corrigan sold 4,900 shares of the stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $70.39, for a total transaction of $344,911.00. Following the sale, the chief executive officer directly owned 83,429 shares of the company’s stock, valued at $5,872,567.31. This represents a 5.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders have sold a total of 9,788 shares of company stock valued at $693,648 in the last three months. Corporate insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on EXPO shares. UBS Group reaffirmed a “neutral” rating and issued a $81.00 price target (up previously from $76.00) on shares of Exponent in a report on Monday, December 15th. JPMorgan Chase & Co. began coverage on Exponent in a research report on Monday, January 26th. They set an “overweight” rating and a $100.00 price target for the company. William Blair raised Exponent from a “market perform” rating to an “outperform” rating in a report on Monday, November 17th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a research note on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $90.50.

Check Out Our Latest Report on EXPO

Exponent Stock Up 12.7%

Shares of EXPO opened at $79.79 on Monday. The company has a market capitalization of $3.98 billion, a price-to-earnings ratio of 38.36 and a beta of 0.79. Exponent, Inc. has a 52 week low of $63.81 and a 52 week high of $97.57. The stock’s 50-day moving average price is $73.00 and its 200-day moving average price is $70.96.

Exponent (NASDAQ:EXPOGet Free Report) last announced its quarterly earnings results on Thursday, February 5th. The business services provider reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.02. Exponent had a return on equity of 25.51% and a net margin of 18.21%.The company had revenue of $147.43 million during the quarter, compared to analysts’ expectations of $128.48 million. During the same period last year, the business earned $0.46 earnings per share. Exponent’s quarterly revenue was up 4.5% on a year-over-year basis. As a group, equities analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Exponent declared that its Board of Directors has authorized a stock buyback program on Thursday, October 30th that allows the company to buyback $100.00 million in shares. This buyback authorization allows the business services provider to repurchase up to 3% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board of directors believes its stock is undervalued.

Exponent Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 20th. Shareholders of record on Friday, March 6th will be issued a $0.31 dividend. The ex-dividend date of this dividend is Friday, March 6th. This is a positive change from Exponent’s previous quarterly dividend of $0.30. This represents a $1.24 dividend on an annualized basis and a yield of 1.6%. Exponent’s dividend payout ratio is presently 57.69%.

Trending Headlines about Exponent

Here are the key news stories impacting Exponent this week:

About Exponent

(Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Featured Articles

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.